États-Unis · Plateformes & données · Stocktwits

IOVA Iovance Biotherapeutics Inc

Publié par Stocktwits · États-Unis il y a 1 j

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer.…

Lire l'article complet sur Stocktwits Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stocktwits.com)

IOVA Iovance Biotherapeutics Inc

À lire aussi

Is Berkshire Bending the Rules With Bending Spoons?

Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Lula, Bolsonaro rally supporters on final day before Brazil presidential runoff

First Interstate BancSystem: 3 Key Takeaways for Long-Term Investors

Bank of America resets Tesla forecast as Robotaxi miles double

IOVA Iovance Biotherapeutics Inc

Partager

À lire aussi

Is Berkshire Bending the Rules With Bending Spoons?

Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Lula, Bolsonaro rally supporters on final day before Brazil presidential runoff

First Interstate BancSystem: 3 Key Takeaways for Long-Term Investors

Bank of America resets Tesla forecast as Robotaxi miles double